IMPROVED EXTENDED-ACTION TILMICOSIN AND USE THEREOF IN TREATMENT OF BOVINE RESPIRATORY DISEASE COMPLEX (BRD) AND IN DRY COW PERIOD
    1.
    发明申请
    IMPROVED EXTENDED-ACTION TILMICOSIN AND USE THEREOF IN TREATMENT OF BOVINE RESPIRATORY DISEASE COMPLEX (BRD) AND IN DRY COW PERIOD 审中-公开
    改进的延迟作用药物及其用于治疗牛血清呼吸综合征(BRD)和干中期的用途

    公开(公告)号:US20160367580A1

    公开(公告)日:2016-12-22

    申请号:US14890827

    申请日:2015-02-18

    Abstract: The invention relates to an improved long-acting or extended-release tilmicosin formulation comprising: tilmicosin phosphate in a concentration between 35 and 50% by weight of the total composition; a first co-solvent in a concentration between 8 and 20% by volume, said first co-solvent being propylene glycol; a second co-solvent in a concentration between 5 and 15% by volume, said second co-solvent being ethyl alcohol; and an emulsifier in a concentration between 1.5 and 15% by weight of the total composition, said emulsifier being poloxamer. The invention also relates to the method for producing said improved long-acting tilmicosin formulation.

    Abstract translation: 本发明涉及一种改进的长效或延长释放的替米考星制剂,其包含:总组合物重量的35-50%浓度的替米考星磷酸盐; 浓度为8至20体积%的第一共溶剂,所述第一助溶剂为丙二醇; 浓度为5至15体积%的第二共溶剂,所述第二助溶剂为乙醇; 和浓度为总组合物重量的1.5至15%的乳化剂,所述乳化剂是泊洛沙姆。 本发明还涉及生产所述改进的长效替米考星制剂的方法。

Patent Agency Ranking